Andrew J. Tofe - Concepedia

Author

Andrew J. Tofe

Procter & Gamble (United States)

Also Known As

A J Tofe, Andrew J. Tofe

Publications

495

Citations

H-Index

Concepts

All Affiliations

Procter & Gamble (United States)

About

Andrew J. Tofe is an author at Procter & Gamble (United States) specializing in osteoporosis, orthopaedics, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	192
2	Engineering	4	4	108
3	Biomedical Engineering	4	4	108
4	Health Sciences	2	2	140
5	Biochemistry	1	1	21

Andrew J. Tofe

Publications

466

Citations

H-Index

Page 1

	Year	Citations
Sites and Mechanisms of Localization of Technetium-99m Phosphorus Radiopharmaceuticals in Acute Myocardial Infarcts and other Tissues L. Maximilian Buja, Andrew J. Tofe, Padmakar V. Kulkarni, Journal of Clinical Investigation	1977	206
Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. Marco Chinol, Shankar Vallabhajosula, Stanley J. Goldsmith, PubMed Biological BehaviorHa CarrierOsteoporosisRhenium-186-labeled Hydroxyapatite ParticlesOrthopaedic Surgery	1993	100
Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. John A. Bevan, Andrew J. Tofe, James J. Benedict, PubMed EngineeringImaging AgentBiomedical EngineeringOrthopaedic SurgeryOsteoporosis	1980	40
Clinical, Radiographic, Histologic, and Histomorphometric Comparison of PepGen P-15 Particulate and PepGen P-15 Flow in Extraction Sockets: A Same-Mouth Case Study Jack Hahn, Michael D. Rohrer, Andrew J. Tofe Implant Dentistry	2003	28
Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues Marion D. Francis, Candice L. Slough, Andrew J. Tofe, Calcified Tissue International Tissue EngineeringRegenerative MedicineMechanobiologyBone ImagingBone Health	1976	28
[32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma. Majic S. Potsaid, Robert J. Irwin, Frank P. Castronovo, PubMed UrologyInitial Safety StudyBone-marrow DepressionPainful Bone MetastasesGenitourinary Cancer	1978	24
In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid. Andrew J. Tofe, Marion D. Francis PubMed Tissue EngineeringEngineeringInstant Thin-layer ChromatographyBone RepairBone Agent	1976	21
Gentisic acid: a new stabilizer for low tin skeletal imaging agents: concise communication. Andrew J. Tofe, John A. Bevan, Mahdi B. Fawzi, PubMed EngineeringNew StabilizerBiomedical EngineeringSkeletal ImagingOsteoporosis	1980	19

Page 1